These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9805817)

  • 41. Advanced glycosylated end products and hyperglycemia in the pathogenesis of diabetic complications.
    Friedman EA
    Diabetes Care; 1999 Mar; 22 Suppl 2():B65-71. PubMed ID: 10097902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Naturally occurring inhibitors against the formation of advanced glycation end-products.
    Peng X; Ma J; Chen F; Wang M
    Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Maillard reaction products in food as pro-inflammatory and pro-arteriosclerotic factors of degenerative diseases].
    Webster J; Wilke M; Stahl P; Kientsch-Engel R; Münch G
    Z Gerontol Geriatr; 2005 Oct; 38(5):347-53. PubMed ID: 16244820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Oxidative stress and diabetes mellitus: a possible role of alpha-dicarbonyl compounds in free radical formation].
    Araki A
    Nihon Ronen Igakkai Zasshi; 1997 Sep; 34(9):716-20. PubMed ID: 9430981
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Maillard reaction. From nutritional problems to preventive medicine.
    Robert L; Labat-Robert J; Robert AM
    Pathol Biol (Paris); 2010 Jun; 58(3):200-6. PubMed ID: 19896300
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Advanced glycation and lipoxidation end products--amplifiers of inflammation: the role of food.
    Bengmark S
    JPEN J Parenter Enteral Nutr; 2007; 31(5):430-40. PubMed ID: 17712153
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pathological implications of protein glycation.
    Brownlee M
    Clin Invest Med; 1995 Aug; 18(4):275-81. PubMed ID: 8549013
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhanced interaction of advanced glycation end products with their cellular receptor RAGE: implications for the pathogenesis of accelerated periodontal disease in diabetes.
    Lalla E; Lamster IB; Schmidt AM
    Ann Periodontol; 1998 Jul; 3(1):13-9. PubMed ID: 9722686
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Advances in the Maillard reaction and glycation researches--mainly on the Namiki pathway].
    Namiki M
    Seikagaku; 2003 Jan; 75(1):37-42. PubMed ID: 12645131
    [No Abstract]   [Full Text] [Related]  

  • 50. [Pentosidine: a new biomarker in diabetes mellitus complications].
    Morales S; García-Salcedo JA; Muñoz-Torres M
    Med Clin (Barc); 2011 Mar; 136(7):298-302. PubMed ID: 20226481
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
    Dyer DG; Dunn JA; Thorpe SR; Bailie KE; Lyons TJ; McCance DR; Baynes JW
    J Clin Invest; 1993 Jun; 91(6):2463-9. PubMed ID: 8514858
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-enzymatic glycation of proteins: a cause for complications in diabetes.
    Nawale RB; Mourya VK; Bhise SB
    Indian J Biochem Biophys; 2006 Dec; 43(6):337-44. PubMed ID: 17285797
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Maillard reaction products and chronic diabetic complications].
    Trivin F; Chevenne D; Hautecouverture M
    Ann Biol Clin (Paris); 1999; 57(4):445-54. PubMed ID: 10432367
    [No Abstract]   [Full Text] [Related]  

  • 54. Possible participation of advanced glycation end products in the pathogenesis of osteoporosis in diabetic patients.
    Yamagishi S; Nakamura K; Inoue H
    Med Hypotheses; 2005; 65(6):1013-5. PubMed ID: 16146671
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glycation and cardiovascular disease in diabetes: A perspective on the concept of metabolic memory.
    Yamagishi SI; Nakamura N; Matsui T
    J Diabetes; 2017 Feb; 9(2):141-148. PubMed ID: 27556881
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Advanced Glycation End Products Enhance Macrophages Polarization into M1 Phenotype through Activating RAGE/NF-κB Pathway.
    Jin X; Yao T; Zhou Z; Zhu J; Zhang S; Hu W; Shen C
    Biomed Res Int; 2015; 2015():732450. PubMed ID: 26114112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pyridoxamine inhibits maillard reactions in diabetic rat lenses.
    Padival S; Nagaraj RH
    Ophthalmic Res; 2006; 38(5):294-302. PubMed ID: 16974131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Potential of birds to serve as pathology-free models of type 2 diabetes, part 2: do high levels of carbonyl-scavenging amino acids (e.g., taurine) and low concentrations of methylglyoxal limit the production of advanced glycation end-products?
    Szwergold BS; Miller CB
    Rejuvenation Res; 2014 Aug; 17(4):347-58. PubMed ID: 24684667
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pharmacological modulation of the advanced glycosylation reaction.
    Brownlee M
    Prog Clin Biol Res; 1989; 304():235-48. PubMed ID: 2675030
    [No Abstract]   [Full Text] [Related]  

  • 60. AGE/RAGE axis in the development of abdominal aortic aneurysm.
    Fujita T
    Ann Surg; 2010 Jul; 252(1):203-5; author reply 205. PubMed ID: 20562684
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.